Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8452 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8199 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7975 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7967 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7967 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7964 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7953 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7886 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7816 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7688 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7669 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7634 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7634 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD2801 |
Approved |
0.759 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7542 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7529 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7514 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7455 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7418 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7414 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD454 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7293 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7251 |
Intermediate Similarity |
NPD920 |
Approved |
0.725 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7235 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7235 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD6312 |
Discontinued |
0.7207 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7135 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1184 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD2344 |
Approved |
0.712 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD958 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7062 |
Intermediate Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD3819 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD957 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6977 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6971 |
Remote Similarity |
NPD3226 |
Approved |
0.6966 |
Remote Similarity |
NPD2379 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD2309 |
Approved |
0.6951 |
Remote Similarity |
NPD3268 |
Approved |
0.6946 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD919 |
Approved |
0.6936 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2346 |
Discontinued |
0.691 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6905 |
Remote Similarity |
NPD5588 |
Approved |
0.6901 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD9717 |
Approved |
0.6868 |
Remote Similarity |
NPD1247 |
Approved |
0.6867 |
Remote Similarity |
NPD943 |
Approved |
0.6852 |
Remote Similarity |
NPD2797 |
Approved |
0.6842 |
Remote Similarity |
NPD2654 |
Approved |
0.6839 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD4972 |
Discontinued |
0.6831 |
Remote Similarity |
NPD5710 |
Approved |
0.6831 |
Remote Similarity |
NPD5711 |
Approved |
0.6825 |
Remote Similarity |
NPD8312 |
Approved |
0.6825 |
Remote Similarity |
NPD8313 |
Approved |
0.6821 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6816 |
Remote Similarity |
NPD7584 |
Approved |
0.6813 |
Remote Similarity |
NPD422 |
Phase 1 |
0.681 |
Remote Similarity |
NPD2798 |
Approved |
0.6798 |
Remote Similarity |
NPD5890 |
Approved |
0.6798 |
Remote Similarity |
NPD5889 |
Approved |
0.6793 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.679 |
Remote Similarity |
NPD3225 |
Approved |
0.6788 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6784 |
Remote Similarity |
NPD4534 |
Discontinued |
0.678 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6768 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD1613 |
Approved |
0.6747 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6743 |
Remote Similarity |
NPD1578 |
Phase 2 |
0.6726 |
Remote Similarity |
NPD1933 |
Approved |
0.6722 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.672 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6706 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6686 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6685 |
Remote Similarity |
NPD4288 |
Approved |
0.6684 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6667 |
Remote Similarity |
NPD3972 |
Approved |
0.6667 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6667 |
Remote Similarity |
NPD9545 |
Approved |
0.6649 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6649 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6649 |
Remote Similarity |
NPD4287 |
Approved |
0.6648 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6646 |
Remote Similarity |
NPD3266 |
Approved |
0.6646 |
Remote Similarity |
NPD3267 |
Approved |
0.6627 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6609 |
Remote Similarity |
NPD7003 |
Approved |
0.6606 |
Remote Similarity |
NPD1852 |
Discontinued |
0.66 |
Remote Similarity |
NPD6780 |
Approved |
0.66 |
Remote Similarity |
NPD6778 |
Approved |
0.66 |
Remote Similarity |
NPD6781 |
Approved |
0.66 |
Remote Similarity |
NPD6782 |
Approved |
0.66 |
Remote Similarity |
NPD6776 |
Approved |
0.66 |
Remote Similarity |
NPD6779 |
Approved |
0.66 |
Remote Similarity |
NPD6777 |
Approved |
0.6596 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.659 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6587 |
Remote Similarity |
NPD2598 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6584 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6584 |
Remote Similarity |
NPD7698 |
Approved |
0.6584 |
Remote Similarity |
NPD7697 |
Approved |
0.6575 |
Remote Similarity |
NPD7577 |
Discontinued |
0.657 |
Remote Similarity |
NPD5406 |
Approved |
0.657 |
Remote Similarity |
NPD5405 |
Approved |
0.657 |
Remote Similarity |
NPD5404 |
Approved |
0.657 |
Remote Similarity |
NPD5408 |
Approved |
0.6566
|
Remote Similarity |
NPD2861 |
Phase 2 |